CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | ¥1 | ¥1 | ¥1 | ¥1 |
| % Growth | -10.4% | 2.7% | 14.4% | – |
| Cost of Goods Sold | ¥0 | ¥0 | ¥0 | ¥0 |
| Gross Profit | ¥0 | ¥1 | ¥1 | ¥0 |
| % Margin | 54.9% | 57.7% | 57.2% | 54.9% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥0 | ¥0 | ¥0 | ¥1 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥0 | ¥0 | ¥0 | ¥1 |
| Operating Income | ¥0 | ¥0 | ¥0 | -¥0 |
| % Margin | 4.9% | 10.7% | 8.2% | -7.3% |
| Other Income/Exp. Net | -¥0 | ¥0 | ¥0 | ¥0 |
| Pre-Tax Income | -¥0 | ¥0 | ¥0 | -¥0 |
| Tax Expense | ¥0 | ¥0 | ¥0 | -¥0 |
| Net Income | -¥0 | ¥0 | ¥0 | -¥0 |
| % Margin | -8.5% | 7.5% | 5.8% | -5.4% |
| EPS | -3.82 | 3.79 | 2.86 | -2.3 |
| % Growth | -200.8% | 32.5% | 224.3% | – |
| EPS Diluted | -3.8 | 3.78 | 2.86 | -2.3 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥0 | ¥0 | ¥0 | -¥0 |
| % Margin | 3.6% | 16.1% | 13.1% | -0.5% |